Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Congratualtions to Bio-Thera on obtaining NMPA’s approval of clinical trials of BAT1308

2020-06-04
|
Page View:

Congratualtions to Medicilon’s partner, Bio-Thera, on obtaining NMPA’s approval of clinical trials of BAT1308.

On May 27th, 2020, Bio-Thera Solutions, Ltd, annouced the approval of clinical trials on BAT 1308, an anti PD-1 monoclonal antibody.
Medicilon participated in BAT 1308’s preclinical study by conducting the In Vivo PK test and safety evaluation tests under GLP.

Related Articles

In Vitro Evaluation of Antibodies
Targeting IL-23, Medicilon Assists the Development of a Variety of New Drugs for Psoriasis

Return
Relevant newsRelevant news